Here are the five latest drugs or medical devices approved by the Food and Drug Administration in the past week.
1. Merck's HIV drug Isentress is now available as a higher-dose, once-daily formula.
2. Rebinyn is intended to treat adults and children with hemophilia B, an inherited blood disorder that causes prolonged or spontaneous bleeding.
3. Atomoxetine is a generic version of Eli Lilly's attention-deficit/hyperactivity disorder drug, Strattera.
4. Zykadia may now be used as a first-line treatment for patients with metastatic non-small cell lung cancer whose tumors carry a specific enzyme identified through an FDA-approved test.
5. Nebivolol represents the first generic version of the hypertension drug Bystolic.
More articles on supply chain:
FDA OKs higher dose of Merck's HIV drug
DHL exec: 3 tech solutions innovating healthcare supply chain
Exact Sciences stock jumps 12% after UnitedHealth issues positive coverage for Cologuard